Arkolith/Insider Trading/ZVSA/Form 4

INCON Co., Ltd.

10% OwnerZyVersa Therapeutics, Inc. (ZVSA) · full profile →Form 4 · filed Dec 16, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2022Grant(A)1.5M—$01.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2022Grant(A)451K—$0451K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-035808) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML